Last reviewed · How we verify
Injection, placebo of toxin + corticoid — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Injection, placebo of toxin + corticoid (Injection, placebo of toxin + corticoid) — Assistance Publique - Hôpitaux de Paris. This is a placebo injection combining an inactivated toxin with a corticosteroid, designed to test the efficacy and safety of toxin-based immunotherapy with anti-inflammatory corticoid co-administration.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Injection, placebo of toxin + corticoid TARGET | Injection, placebo of toxin + corticoid | Assistance Publique - Hôpitaux de Paris | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Injection, placebo of toxin + corticoid CI watch — RSS
- Injection, placebo of toxin + corticoid CI watch — Atom
- Injection, placebo of toxin + corticoid CI watch — JSON
- Injection, placebo of toxin + corticoid alone — RSS
Cite this brief
Drug Landscape (2026). Injection, placebo of toxin + corticoid — Competitive Intelligence Brief. https://druglandscape.com/ci/injection-placebo-of-toxin-corticoid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab